<DOC>
	<DOCNO>NCT00490516</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled parallel-group , 6-week study , evaluate two dose level ACP-104 Placebo twice day patient schizophrenia experience acute psychotic episode .</brief_summary>
	<brief_title>ACP-104 Acutely Psychotic Subjects With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Male female ; 1860 year age The subject physically healthy medically stable . The subject able provide inform consent The subject diagnose schizophrenia least 1 year Currently experience acute episode psychosis The subject willing comply studyrelated event include inpatient hospitalization least 3 week . The subject caregiver willing able support subject ensure compliance treatment outpatient visit . If subject female , subject must nonchildbearing potential OR capable become pregnant , agree commit use one approve method contraception , define protocol . If subject pregnant lactating ( breastfeed ) female . The subject significant risk suicide , homicide , and/or harm self others . Subject 's psychotic symptom improve therapeutic dose antipsychotic treatment last 2 year . The subject experience his/her first episode schizophrenia . The subject another psychotic disorder history autistic disorder pervasive developmental disorder ( example , mental retardation ) . The subject prescribe exposed clozapine . The subject donate blood plasma within 56 day prior Screening Visit . The subject participate clinical study within 30 day prior Screening Visit . In addition criterion describe , subject evaluate screen ensure criterion study participation met . These evaluation include specific measure subject 's health , include psychosis ( mental health extent subject unable think clearly ) , heart condition , pregnancy status . Patients may exclude study base assessment ( specifically determine baseline condition meet protocolspecified entry criterion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Schizophrenia , psychotic disorder</keyword>
</DOC>